NCT04829708View on ClinicalTrials.gov

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

534

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

April 15, 2026

Study Completion Date

April 15, 2028

Conditions
Limited Stage Small Cell Lung Cancer
Interventions
OTHER

MRI Surveillance

Receive MRI surveillance

RADIATION

Prophylactic Cranial Irradiation

Receive PCI

Trial Locations (2)

250117

RECRUITING

Shandong Cancer Hospital and Institute, Jinan

Unknown

RECRUITING

Shandong Cancer Hospital, Jinan

All Listed Sponsors
lead

Shandong Cancer Hospital and Institute

OTHER

NCT04829708 - Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy | Biotech Hunter | Biotech Hunter